• New cancer immunotherapy treatment enters clinical phase

    Thursday April 29th 2021

  • Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies

    Friday April 23rd 2021

  • PCR speekseltesten op de werkvloer identificeren besmette laag-risico contacten zonder symptomen en helpen de verdere verspreiding tegengaan

    Monday April 19th 2021

  • Mayne Pharma and Mithra announce FDA approval of new oral contraceptive EstelleĀ®

    Friday April 16th 2021

  • ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version

    Monday March 22nd 2021

  • Cardiology prepared for fourth dimension

    Friday March 5th 2021

  • Sarcura and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation

    Thursday February 25th 2021

  • Preventieve speekseltest voor het opsporen van het COVID-19 virus is nu beschikbaar voor bedrijven en organisaties

    Tuesday February 23rd 2021

  • Your news here?

  • Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring

    Wednesday February 10th 2021

  • Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study

    Tuesday December 22nd 2020

  • GSK meets Belgian Universities

    Tuesday October 27th 2020


Strategic Partners